- Home
- NRGV vs MDXG Comparison
NRGV vs MDXG Comparison
Compare NRGV & MDXG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | NRGV | MDXG |
|---|---|---|
| Founded | 2017 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Biotechnology: Pharmaceutical Preparations |
| Sector | Miscellaneous | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 785.5M | 625.6M |
| IPO Year | 2021 | 2007 |
Fundamental Metrics
Financial Performance| Metric | NRGV | MDXG |
|---|---|---|
| Price | $4.86 | $4.94 |
| Analyst Decision | Strong Sell | Strong Buy |
| Analyst Count | 1 | 6 |
| Target Price | $2.00 | ★ $9.00 |
| AVG Volume (30 Days) | ★ 3.4M | 902.2K |
| Earning Date | 05-05-2026 | 04-29-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 28.57 | 14.29 |
| EPS | N/A | ★ N/A |
| Revenue | $203,671,000.00 | ★ $418,630,000.00 |
| Revenue This Year | $28.93 | N/A |
| Revenue Next Year | $16.69 | $13.02 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 340.86 | 19.99 |
| 52 Week Low | $2.50 | $3.03 |
| 52 Week High | $6.65 | $7.97 |
Technical Indicators
Market Signals| Indicator | NRGV | MDXG |
|---|---|---|
| Relative Strength Index (RSI) | 67.65 | 67.78 |
| Support Level | $4.38 | $4.11 |
| Resistance Level | $4.88 | $5.38 |
| Average True Range (ATR) | 0.32 | 0.18 |
| MACD | 0.07 | 0.01 |
| Stochastic Oscillator | 97.90 | 86.73 |
Price Performance
Historical ComparisonAbout NRGV Energy Vault Holdings Inc.
Energy Vault Holdings Inc is a diversified portfolio of energy storage solutions to third parties, including proprietary gravity, battery, and green hydrogen-based technologies, supported by technology-agnostic energy management software and integration capabilities. Geographical presence in the United States, Australia, and other countries. The majority of its revenue comes from Australia.
About MDXG MiMedx Group Inc
MiMedx Group Inc develops and markets regenerative biomaterial products and bioimplants made from the human amniotic membrane, birth tissues, and human skin & bone. Its products are targeted towards the wound-care, burn, surgical, sports medicine, and orthopedics markets. MiMedx's key products are allografts processed from amniotic tissue, which include EpiFix for external use and AmnioFix for internal use. AmnioCord, AmnioFill, EpiBurn, and EpiCord are some of its other products. Also, the company sells allografts for ophthalmic surgery and dental applications through licenses to third parties.